TrialInternational journal of molecular sciences2013

L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.

Tomohiko Kanaoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.